{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:11:48Z","timestamp":1778825508600,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T00:00:00Z","timestamp":1469404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["083844\/z\/07\/Z"],"award-info":[{"award-number":["083844\/z\/07\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.vaccine.2016.07.028","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T09:41:29Z","timestamp":1469180489000},"page":"4378-4385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Strain-dependent and distinctive T-cell responses to HIV antigens following immunisation of mice with differing chimpanzee adenovirus vaccine vectors"],"prefix":"10.1016","volume":"34","author":[{"given":"S.","family":"Herath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Le Heron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Colloca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Tatoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.07.028_b0005","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.4049\/jimmunol.1202861","article-title":"Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization","volume":"190","author":"Quinn","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.07.028_b0010","doi-asserted-by":"crossref","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.07.028_b0015","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/COH.0b013e32833cfe4c","article-title":"Novel adenovirus vector-based vaccines for HIV-1","volume":"5","author":"Barouch","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.vaccine.2016.07.028_b0020","doi-asserted-by":"crossref","first-page":"115ra2","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2016.07.028_b0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"Kiepiela","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.07.028_b0030","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2013.09.061","article-title":"Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys","volume":"155","author":"Barouch","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2016.07.028_b0035","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.4049\/jimmunol.178.5.2746","article-title":"Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression","volume":"178","author":"Sacha","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.07.028_b0040","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mt.2013.248","article-title":"Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1","volume":"22","author":"Borthwick","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2016.07.028_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.10.111","article-title":"Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag-pol-nef antigen","author":"Herath","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.028_b0050","unstructured":"Search P. <http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=mouse+and+HIV>."},{"key":"10.1016\/j.vaccine.2016.07.028_b0055","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.4049\/jimmunol.175.6.3819","article-title":"The H-2Kk MHC peptide-binding groove anchors the backbone of an octameric antigenic peptide in an unprecedented mode","volume":"175","author":"Kellenberger","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.07.028_b0060","doi-asserted-by":"crossref","first-page":"10618","DOI":"10.1074\/jbc.M510511200","article-title":"Structural definition of the H-2Kd peptide-binding motif","volume":"281","author":"Mitaksov","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2016.07.028_b0065","doi-asserted-by":"crossref","first-page":"8403","DOI":"10.1073\/pnas.89.17.8403","article-title":"Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition","volume":"89","author":"Zhang","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.07.028_b0070","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1074-7613(00)80560-9","article-title":"Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes","volume":"8","author":"Speir","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2016.07.028_b0075","doi-asserted-by":"crossref","first-page":"e73117","DOI":"10.1371\/journal.pone.0073117","article-title":"Nef-specific CD8+ T cell responses contribute to HIV-1 immune control","volume":"8","author":"Adland","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.07.028_b0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/hiv.12310","article-title":"Immune activation in the course of HIV-1 infection: causes, phenotypes and persistence under therapy","volume":"17","author":"Younas","year":"2016","journal-title":"HIV Med"},{"key":"10.1016\/j.vaccine.2016.07.028_b0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbrc.2009.04.134","article-title":"The role of CD4 T cell help for CD8 CTL activation","volume":"384","author":"Zhang","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2016.07.028_b0090","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"Quinn","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2016.07.028_b0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/0300985811429314","article-title":"Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice","volume":"49","author":"Sellers","year":"2012","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2016.07.028_b0100","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.vaccine.2015.01.042","article-title":"The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species","volume":"33","author":"Dicks","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T09:23:34Z","timestamp":1536571414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16306119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":20,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0264410X16306119"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strain-dependent and distinctive T-cell responses to HIV antigens following immunisation of mice with differing chimpanzee adenovirus vaccine vectors","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}